Stefan Scherer

Stefan Scherer

Company: 3T Biosciences

Job title: Chief Executive Officer


Identification of Novel pHLA Targets for Solid Tumor 9:30 am

Advantages of intracellular targets (pHLAs) versus viral, neoantigens or conventional cell surface antigens Strategies to find the most prevalent and immunogenic pHLA targets in tumors of CPI responders Selection of self-antigen targets with highest tumor vs normal ratios to avoid off-tumor, on-target toxicities of TCR based therapiesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.